Skip to main content

Artemis Therapeutics, Inc. (ATMS)

OTCMKTS: ATMS · Delayed Price · USD
1.25 0.00 (0.00%)
Sep 17, 2021 3:12 PM EDT - Market closed
Market Cap6.44M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out5.15M
EPS (ttm)-0.03
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,210
Open1.25
Previous Close1.25
Day's Range1.25 - 1.25
52-Week Range0.14 - 7.02
Beta0.44
Analystsn/a
Price Target3.50 (+180.0%)
Est. Earnings Daten/a

About ATMS

Artemis Therapeutics Inc. does not have significant operations. Previously, it was engaged in the development of agents for the prevention and treatment of severe and life-threatening infectious diseases. The company is based in New York, New York. Artemis Therapeutics Inc. is a subsidiary of Tonak Ltd.

IndustryPharmaceuticals
Stock ExchangeOTCMKTS
Ticker SymbolATMS
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.